Jayson Dallas

Inga fler pågående positioner

58 år

Health Technology

Consumer Services

Profil

Jayson Donald Alexander Dallas worked at Genentech, Inc. as Head-Global Product Strategy Inflammation from 2010 to 2012.
He was General Manager at Roche Holding (UK) Ltd. from 2013 to 2015.
He served as Chief Commercial Officer & Senior Vice President at Ultragenyx Pharmaceutical, Inc. from 2016 to 2018.
He was President, Chief Executive Officer & Director at Aimmune Therapeutics, Inc. from 2018 to 2020.
He held the position of Independent Director at Arena Pharmaceuticals, Inc. from 2017 to 2022 and at Damora Therapeutics, Inc. from 2020 to 2026.
He was Chief Executive Officer & Director at Rivus Pharmaceuticals, Inc. from 2023 to 2025.
Education includes undergraduate studies at Knox College, a doctorate from the University of the Witwatersrand, and an MBA from Ashridge Business School.

Tidigare kända positioner av Jayson Dallas

Företag	Position	Slut
DAMORA THERAPEUTICS, INC.	Direktör/Styrelseledamot	2026-03-23
Rivus Pharmaceuticals, Inc. Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Verkställande Direktör	2025-07-03
ARENA PHARMACEUTICALS	Direktör/Styrelseledamot	2022-03-11
AIMMUNE THERAPEUTICS, INC.	Verkställande Direktör	2020-12-01
ULTRAGENYX PHARMACEUTICAL INC.	Företagsledare/Principal	2018-06-18

Se detaljerna i Jayson Dallass erfarenhet

Jayson Dallass utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Jayson Dallass erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	10
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Knox College Knox College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Roche Holding (UK) Ltd. Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells drugs	Health Technology
University of the Witwatersrand University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ashridge Business School Ashridge Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies	Health Technology
Galecto, Inc. Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases	Health Technology
Rivus Pharmaceuticals, Inc. Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology